Biblioteca Virtual em Saúde

Pesquisa | Influenza A (H1N1)

  • BIREME | OPAS | OMS logo
 

Histórico de pesquisa  ()

Sua seleção  ()

 0 documento(s) selecionado(s).

Refine sua pesquisa

Collapse All  Ocultar
Expand All  Mostrar
Áreas temáticas
Texto completo (789)
Idioma
Ano de publicação

Enviar por email

Você tem 0 documento(s) selecionado(s).

Nenhum documento selecionado

 
Resultados  1-12 de 889
2.

Recommended composition of influenza virus vaccines for use in the 2017–2018 northern hemisphere influenza season – Composition recommandée des vaccins antigrippaux pour la saison grippale 2017-2018 dans l’hémisphère Nord

Autor(es): World Health Organization = Organisation mondiale de la Santé
Fonte: Geneva = Genève; World Health Organization = Organisation mondiale de la Santé; 2017-03-17. , 92, 11
WHOLIS - Sistema de Informação da Biblioteca da OMS ID: 254758
3.

Heterologous Immune Responses to Influenza Vaccine in Kidney Transplant Recipients.

Autor(es): Kumar, D; Ferreira, V H; Campbell, P; Hoschler, K; Humar, A
Fonte: Am J Transplant;17(1): 281-286, 2017 Jan.
MEDLINE - Literatura Internacional em Ciências da Saúde PMID: 27402204
Resumo: Influenza vaccine is known to have suboptimal immunogenicity in transplant recipients. Despite this, influenza vaccine may have the added benefit of inducing a cross-reactive immune response to viral strains not found in the vaccine. This is termed "heterologous immunity" and has not been assessed previously in transplant patients. Pre- and postvaccination sera from kidney transplant recipients (n = 60) immunized with the 2012-2013 adjuvanted or nonadjuvanted influenza vaccine underwent tes (mais)
4.

Perceived concern about the new strain of the influenza and obtaining the vaccine in China, Japan and South Korea.

Autor(es): Kamimura, Akiko; Armenta, Bianca A; Nourian, Maziar M; Wright, Lindsey; Rathi, Naveen; Chernenko, Alla
Fonte: J Infect Public Health;10(3): 251-257, 2017 May - Jun.
MEDLINE - Literatura Internacional em Ciências da Saúde PMID: 27423930
Resumo: This study compares the factors, which influence individuals from the countries of China, Japan and South Korea to obtain any type of influenza vaccines and their perceived concerns about the new strain of the influenza - pandemic (H1N1) 2009. The data analyzed was from the East Asian Social Survey (EASS), Cross-National Survey Data Sets: Health and Society in East Asia, 2010 (ICPSR 34608) (N=7938). The results of this study suggest that individuals who are concerned about the new strain of (mais)
5.

Impact of pharmacist administration of influenza vaccines on uptake in Canada.

Autor(es): Buchan, Sarah A; Rosella, Laura C; Finkelstein, Michael; Juurlink, David; Isenor, Jennifer; Marra, Fawziah; Patel, Anik; Russell, Margaret L; Quach, Susan; Waite, Nancy; Kwong, Jeffrey C
Fonte: CMAJ;189(4): E146-E152, 2017 Jan 30.
MEDLINE - Literatura Internacional em Ciências da Saúde PMID: 27503864
Resumo: BACKGROUND: Uptake of influenza vaccination in Canada remains suboptimal despite widespread public funding. To increase access, several provinces have implemented policies permitting pharmacists to administer influenza vaccines in community pharmacies. We examined the impact of such policies on the uptake of seasonal influenza vaccination in Canada. METHODS: We pooled data from the 2007-2014 cycles of the Canadian Community Health Survey ( = 481 526). To determine the impact of influenza va (mais)
6.

Reassortment of high-yield influenza viruses in vero cells and safety assessment as candidate vaccine strains.

Autor(es): Zhou, Jian; Yang, Fan; Yang, Jinghui; Ma, Lei; Cun, Yina; Song, Shaohui; Liao, Guoyang
Fonte: Hum Vaccin Immunother;13(1): 111-116, 2017 Jan 02.
MEDLINE - Literatura Internacional em Ciências da Saúde PMID: 27648636
Resumo: Vaccination is the practiced and accessible measure for preventing influenza infection. Because chicken embryos used for vaccine production have various insufficiencies, more efficient methods are needed. African green monkey kidney (Vero) cells are recommended by the World Health Organization (WHO) as a safe substitute for influenza vaccine production for humans. However, the influenza virus usually had low-yield in Vero cells, which limits the usage of Vero cellular vaccines. This study u (mais)
7.

Sociocultural determinants of anticipated acceptance of pandemic influenza vaccine in Pune, India: a community survey using mixed-methods.

Autor(es): Sundaram, Neisha; Schaetti, Christian; Grize, Leticia; Purohit, Vidula; Joseph, Saju; Schindler, Christian; Kudale, Abhay; Weiss, Mitchell G
Fonte: Int J Public Health;62(1): 103-115, 2017 Jan.
MEDLINE - Literatura Internacional em Ciências da Saúde PMID: 27658812
Resumo: OBJECTIVES: To investigate community priority and determinants of pandemic influenza vaccine acceptance in Pune, India. Community willingness to accept vaccines is often neglected in pandemic preparedness. Despite an acknowledged need, few such studies have been done in lower income countries. METHODS: A cross-sectional, mixed-methods study used semi-structured explanatory model interviews to assess anticipated acceptance of nasal and injectable vaccines at different prices among 436 urban (mais)
8.

Construction of a recombinant duck enteritis virus vaccine expressing hemagglutinin of H9N2 avian influenza virus and evaluation of its efficacy in ducks.

Autor(es): Sun, Ying; Yang, Chenghuai; Li, Junping; Li, Ling; Cao, Minghui; Li, Qihong; Li, Huijiao
Fonte: Arch Virol;162(1): 171-179, 2017 Jan.
MEDLINE - Literatura Internacional em Ciências da Saúde PMID: 27709401
Resumo: H9 subtype avian influenza viruses (AIVs) remain a significant burden in the poultry industry and are considered to be one of the most likely causes of any new influenza pandemic in humans. As ducks play an important role in the maintenance of H9 viruses in nature, successful control of the spread of H9 AIVs in ducks will have significant beneficial effects on public health. Duck enteritis virus (DEV) may be a promising candidate viral vector for aquatic poultry vaccination. In this study, (mais)
9.

Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy.

Autor(es): Nakashima, Kei; Aoshima, Masahiro; Ohfuji, Satoko; Suzuki, Kanzo; Katsurada, Masahiro; Katsurada, Naoko; Misawa, Masafumi; Otsuka, Yoshihito; Kondo, Kyoko; Hirota, Yoshio
Fonte: Hum Vaccin Immunother;13(3): 543-550, 2017 Mar 04.
MEDLINE - Literatura Internacional em Ciências da Saúde PMID: 27820665
Resumo: Lung cancer is a leading cause of cancer-related death, and patients with lung cancer are a priority group for influenza vaccination. However, few studies have assessed the immunogenicity of the influenza vaccine in these patients. Here, we performed a prospective study to evaluate the immunogenicity of the influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy. Twenty-five patients with lung cancer undergoing anticancer chemotherapy and 26 patients with chronic o (mais)
10.

Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines.

Autor(es): Thommes, Edward W; Kruse, Morgan; Kohli, Michele; Sharma, Rohita; Noorduyn, Stephen G
Fonte: Hum Vaccin Immunother;13(4): 867-876, 2017 Apr 03.
MEDLINE - Literatura Internacional em Ciências da Saúde PMID: 27858509
Resumo: In the 2015/16 influenza season, the Canadian National Advisory Committee on Immunization (NACI) recommended vaccination with quadrivalent inactivated influenza vaccine (QIV) for infants aged 6-23 months and trivalent inactivated influenza vaccines (TIVs) or QIVs in adults. The objective of this review (GSK study identifier: HO-13-14054) is to examine the epidemiology and disease burden of influenza in Canada and the economic benefits of vaccination. To inform this review, we performed a s (mais)
11.

Estimating vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings in South Africa, 2015.

Autor(es): McAnerney, Johanna M; Walaza, Sibongile; Tempia, Stefano; Blumberg, Lucille; Treurnicht, Florette K; Madhi, Shabir A; Valley-Omar, Ziyaad; Cohen, Cheryl
Fonte: Influenza Other Respir Viruses;11(2): 177-181, 2017 Mar.
MEDLINE - Literatura Internacional em Ciências da Saúde PMID: 27865064
Resumo: Trivalent seasonal influenza vaccine effectiveness during the 2015 season in South Africa was assessed using a test-negative case control study design. Influenza A(H1N1)pdm09 was the dominant circulating strain. Overall influenza vaccine coverage was 3.2% (29/899). The vaccine effectiveness estimate, against any influenza virus infection, adjusted for age, underlying conditions and timing within season was 46.2% (95% CI: -23.5 to 76.5), and 53.6% (95% CI: -62.6 to 80.3) against influenza A(H1N1)pdm09.
12.

Protection against Streptococcus pneumoniae Invasive Pathogenesis by a Protein-Based Vaccine Is Achieved by Suppression of Nasopharyngeal Bacterial Density during Influenza A Virus Coinfection.

Autor(es): Khan, M Nadeem; Xu, Qingfu; Pichichero, Michael E
Fonte: Infect Immun;85(2)2017 Feb.
MEDLINE - Literatura Internacional em Ciências da Saúde PMID: 27895132
Resumo: An increase in Streptococcus pneumoniae nasopharynx (NP) colonization density during a viral coinfection initiates pathogenesis. To mimic natural S. pneumoniae pathogenesis, we commensally colonized the NPs of adult C57BL/6 mice with S. pneumoniae serotype (ST) 6A or 8 and then coinfected them with mouse-adapted H1N1 influenza A virus (PR/8/34). S. pneumoniae established effective commensal colonization, and influenza virus coinfection caused S. pneumoniae NP density to increase, resulting (mais)
Resultados  1-12 de 889